Optimus was established in the year 2004 as custom synthesis laboratory by a team of Technocrats. It is one of the fastest growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Optimus expanded into global markets and started filing DMFs for both APIs and Intermediates with various Regulatory agencies. Optimus Research Center for API & Formulations was set-up as a centralized Research and Development center to focus on Generic product developments suitable for regulated markets.

Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity) with eight molecules in various stages of clinical development. The company has a significant presence in branded generics markets across emerging economies including India. Its subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business.

Macleods with its experience spanning more than two decades has emerged as a force to reckon with in global pharmaceutical market. With an asset of more than 10,000 professionally qualified employees across the globe, Macleods a multiple location organization, is based out of Mumbai, India.

Indoco Remedies Ltd., is a fully integrated, research-oriented pharma company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). We have seven decades of presence in the Indian Pharma market and a strong foothold in the international market across 55 countries. Indoco, a USD 140 million company, employs around 6000 personnel, including over 300 skilled scientists.